Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2019

Dec 4, 2019

34595_dirs_2019-12-04_061bc04e-502a-462f-a5f7-83e0f5d5d7a9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-12-02

Reporting Person: Sagartz John E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-02 Common Shares A 8974 Acquired 630499 Direct

Footnotes

F1: Represents restricted grant subject to vesting and forfeiture.

F2: Of the 630,499 shares reported, 617,625 shares were previously reported as indirectly held. These shares were distributed to the reporting person as part of a pro-rata distribution from SW Chrysalis, LLC, of which the reporting person is the Co-President and Chief Strategy Officer.